RT @DrMarthaGulati
#TRILUMINATE Pivotal trial #Acc23 #WCCardio
🫀transcath TR with triclip assessed: RCT in those with TR
🫀excluded PH, LVEF<20%
🫀👏🏽👏🏽 56% Women!
🫀⬇️ TR w/ clip and durable at 12m: superior to medical tx but no diff in survival and HF 🏥
🫀⬆️ QOL